Microcirculatory Dysfunction in Sepsis

Critical Care Clinics

Volumn 25, Issue 4, 2009, Pages 721-731

  Lundy, David J ^a   Trzeciak, Stephen ^b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

Author keywords

Microcirculation; Organ failure; Sepsis; Septic shock; Severe sepsis

Indexed keywords

ACETYLCHOLINE; DOBUTAMINE; DROTRECOGIN; GLYCERYL TRINITRATE; INOTROPIC AGENT; NITRIC OXIDE; NITRIC OXIDE DONOR; PROSTACYCLIN; VASODILATOR AGENT;

BLOOD FLOW; CELL ACTIVATION; CRITICAL ILLNESS; DISEASE MODEL; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; ENDOTHELIUM CELL; HEMODYNAMICS; HUMAN; MICROANGIOPATHY; MICROCIRCULATION; MORBIDITY; MORTALITY; NONHUMAN; OXYGENATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SEPSIS; VASODILATATION;

ANIMALS; BLOOD COAGULATION; CAPILLARIES; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; MICROCIRCULATION; MOUTH FLOOR; NITRIC OXIDE; REGIONAL BLOOD FLOW; SEPSIS;

EID: 70350502829     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2009.06.002     Document Type: Review

References (104)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29 7 (2001) 1303-1310
2. Hotchkiss R.S., and Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 348 2 (2003) 138-150
3. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345 19 (2001) 1368-1377
4. Lin S.M., Huang C.D., Lin H.C., et al. A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial. Shock 26 6 (2006) 551-557
5. Jones A.E., Brown M.D., Trzeciak S., et al. The effect of a quantitative resuscitation strategy on mortality in patients with sepsis: a meta-analysis. Crit Care Med 36 10 (2008) 2734-2739
6. Otero R.M., Nguyen H.B., Huang D.T., et al. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest 130 5 (2006) 1579-1595
7. Ellis C.G., Bateman R.M., Sharpe M.D., et al. Effect of a maldistribution of microvascular blood flow on capillary O(2) extraction in sepsis. Am J Physiol Heart Circ Physiol 282 1 (2002) H156-H164
8. Farquhar I., Martin C.M., Lam C., et al. Decreased capillary density in vivo in bowel mucosa of rats with normotensive sepsis. J Surg Res 61 1 (1996) 190-196
9. Fries M., Weil M.H., Sun S., et al. Increases in tissue Pco2 during circulatory shock reflect selective decreases in capillary blood flow. Crit Care Med 34 2 (2006) 446-452
10. Lam C., Tyml K., Martin C., et al. Microvascular perfusion is impaired in a rat model of normotensive sepsis. J Clin Invest 94 5 (1994) 2077-2083
11. De Backer D., Creteur J., Preiser J.C., et al. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 166 1 (2002) 98-104
12. Sakr Y., Dubois M.J., De Backer D., et al. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 32 9 (2004) 1825-1831
13. Aird W.C. Endothelium as an organ system. Crit Care Med 32 5 Suppl (2004) s271-s279
14. Palmer R.M., Ferrige A.G., and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 6122 (1987) 524-526
15. Tyml K., Wang X., Lidington D., et al. Lipopolysaccharide reduces intercellular coupling in vitro and arteriolar conducted response in vivo. Am J Physiol Heart Circ Physiol 281 3 (2001) H1397-H1406
16. Aird W.C. Vascular bed-specific hemostasis: role of endothelium in sepsis pathogenesis. Crit Care Med 29 7 Suppl (2001) s28-s34 [discussion: s34-5]
17. Yan S.B., Helterbrand J.D., Hartman D.L., et al. Low levels of protein C are associated with poor outcome in severe sepsis. Chest 120 3 (2001) 915-922
18. Terada L.S., Hybertson B.M., Connelly K.G., et al. XO increases neutrophil adherence to endothelial cells by a dual ICAM-1 and P-selectin-mediated mechanism. J Appl Physiol 82 3 (1997) 866-873
19. Shapiro N.I., Yano K., Okada H., et al. A prospective, observational study of soluble Flt-1 and vascular endothelial growth factor in sepsis. Shock 29 4 (2008) 452-457
20. Yano K., Liaw P.C., Mullington J.M., et al. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med 203 6 (2006) 1447-1458
21. Bateman R.M., Jagger J.E., Sharpe M.D., et al. Erythrocyte deformability is a nitric oxide-mediated factor in decreased capillary density during sepsis. Am J Physiol Heart Circ Physiol 280 6 (2001) H2848-H2856
22. Condon M.R., Kim J.E., Deitch E.A., et al. Appearance of an erythrocyte population with decreased deformability and hemoglobin content following sepsis. Am J Physiol Heart Circ Physiol 284 6 (2003) H2177-H2184
23. Kempe D.S., Akel A., Lang P.A., et al. Suicidal erythrocyte death in sepsis. J Mol Med 85 3 (2007) 273-281
24. Aird W.C. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101 10 (2003) 3765-3777
25. Azuma H., Ishikawa M., and Sekizaki S. Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 88 2 (1986) 411-415
26. Cambien B., Bergmeier W., Saffaripour S., et al. Antithrombotic activity of TNF-alpha. J Clin Invest 112 10 (2003) 1589-1596
27. Hutcheson I.R., Whittle B.J., and Boughton-Smith N.K. Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 101 4 (1990) 815-820
28. Kubes P., Suzuki M., and Granger D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 88 11 (1991) 4651-4655
29. Mendelsohn M.E., O'Neill S., George D., et al. Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine. J Biol Chem 265 31 (1990) 19028-19034
30. Radomski M.W., Palmer R.M., and Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2 8567 (1987) 1057-1058
31. Radomski M.W., Vallance P., Whitley G., et al. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovasc Res 27 7 (1993) 1380-1382
32. Shultz P.J., and Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 90 5 (1992) 1718-1725
33. Cunha F.Q., Assreuy J., Moss D.W., et al. Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1-beta. Immunology 81 2 (1994) 211-215
34. Morin M.J., Unno N., Hodin R.A., et al. Differential expression of inducible nitric oxide synthase messenger RNA along the longitudinal and crypt-villus axes of the intestine in endotoxemic rats. Crit Care Med 26 7 (1998) 1258-1264
35. Ince C., and Sinaasappel M. Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med 27 7 (1999) 1369-1377
36. Trzeciak S., Dellinger R.P., Parrillo J.E., et al. Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med 49 1 (2007) 88-98 98, e1-2
37. Doerschug K.C., Delsing A.S., Schmidt G.A., et al. Impairments in microvascular reactivity are related to organ failure in human sepsis. Am J Physiol Heart Circ Physiol 293 2 (2007) H1065-H1071
38. Vincent J.L., and De Backer D. Microvascular dysfunction as a cause of organ dysfunction in severe sepsis. Crit Care 9 Suppl 4 (2005) s9-s12
39. Levy M.M., Macias W.L., Vincent J.L., et al. Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med 33 10 (2005) 2194-2201
40. Shapiro N., Howell M.D., Bates D.W., et al. The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med 48 5 (2006) 583-590 590, e1
41. Trzeciak S., McCoy J.V., Phillip Dellinger R., et al. Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis. Intensive Care Med 34 12 (2008) 2210-2217
42. Goedhart P.T., Khalilzada M., Bezemer R., et al. Sidestream Dark Field (SDF) imaging: a novel stroboscopic LED ring-based imaging modality for clinical assessment of the microcirculation. Opt Express 15 (2007) 15101-15114
43. Groner W., Winkelman J.W., Harris A.G., et al. Orthogonal polarization spectral imaging: a new method for study of the microcirculation. Nat Med 5 10 (1999) 1209-1212
44. Harris A.G., Sinitsina I., and Messmer K. The Cytoscan Model E-II, a new reflectance microscope for intravital microscopy: comparison with the standard fluorescence method. J Vasc Res 37 6 (2000) 469-476
45. Mathura K.R., Vollebregt K.C., Boer K., et al. Comparison of OPS imaging and conventional capillary microscopy to study the human microcirculation. J Appl Physiol 91 1 (2001) 74-78
46. Mazzarelli J., Guglielmi M., Ross F., et al. Leukocyte dynamics measured by orthogonal polarization spectral imaging correlate with video microscopy. [abstract]. Shock 23 Suppl 3 (2005) 122
47. Creteur J., De Backer D., Sakr Y., et al. Sublingual capnometry tracks microcirculatory changes in septic patients. Intensive Care Med 32 4 (2006) 516-523
48. Marik P.E. Sublingual capnography: a clinical validation study. Chest 120 3 (2001) 923-927
49. Nakagawa Y., Weil M.H., Tang W., et al. Sublingual capnometry for diagnosis and quantitation of circulatory shock. Am J Respir Crit Care Med 157 6 Pt 1 (1998) 1838-1843
50. Weil M.H., Nakagawa Y., Tang W., et al. Sublingual capnometry: a new noninvasive measurement for diagnosis and quantitation of severity of circulatory shock. Crit Care Med 27 7 (1999) 1225-1229
51. Jin X., Weil M.H., Sun S., et al. Decreases in organ blood flows associated with increases in sublingual PCO2 during hemorrhagic shock. J Appl Physiol 85 6 (1998) 2360-2364
52. Povoas H.P., Weil M.H., Tang W., et al. Comparisons between sublingual and gastric tonometry during hemorrhagic shock. Chest 118 4 (2000) 1127-1132
53. Povoas H.P., Weil M.H., Tang W., et al. Decreases in mesenteric blood flow associated with increases in sublingual PCO2 during hemorrhagic shock. Shock 15 5 (2001) 398-402
54. De Backer D., Creteur J., Noordally O., et al. Does hepato-splanchnic VO2/DO2 dependency exist in critically ill septic patients?. Am J Respir Crit Care Med 157 4 Pt 1 (1998) 1219-1225
55. Guzman J.A., Lacoma F.J., and Kruse J.A. Relationship between systemic oxygen supply dependency and gastric intramucosal PCO2 during progressive hemorrhage. J Trauma 44 4 (1998) 696-700
56. Nelson D.P., Beyer C., Samsel R.W., et al. Pathological supply dependence of O2 uptake during bacteremia in dogs. J Appl Physiol 63 4 (1987) 1487-1492
57. Boerma E.C., Van der Voort P.H., Spronk P.E., et al. Relationship between sublingual and intestinal microcirculatory perfusion in patients with abdominal sepsis. Crit Care Med 35 4 (2007) 1055-1060
58. De Backer D., Hollenberg S., Boerma C., et al. How to evaluate the microcirculation: report of a round table conference. Crit Care 11 5 (2007) R101
59. Bihari D., Smithies M., Gimson A., et al. The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients. N Engl J Med 317 7 (1987) 397-403
60. Shoemaker W.C., Appel P.L., Kram H.B., et al. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 94 6 (1988) 1176-1186
61. De Backer D., Creteur J., Dubois M.J., et al. The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med 34 2 (2006) 403-408
62. De Backer D., Verdant C., Chierego M., et al. Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis. Crit Care Med 34 7 (2006) 1918-1924
63. Hoffmann J.N., Vollmar B., Laschke M.W., et al. Microcirculatory alterations in ischemia-reperfusion injury and sepsis: effects of activated protein C and thrombin inhibition. Crit Care 9 Suppl 4 (2005) s33-s37
64. Iba T., Kidokoro A., Fukunaga M., et al. Activated protein C improves the visceral microcirculation by attenuating the leukocyte-endothelial interaction in a rat lipopolysaccharide model. Crit Care Med 33 2 (2005) 368-372
65. Baker C.H., and Wilmoth F.R. Microvascular responses to E. coli endotoxin with altered adrenergic activity. Circ Shock 12 3 (1984) 165-176
66. Hollenberg S.M., Broussard M., Osman J., et al. Increased microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide synthase. Circ Res 86 7 (2000) 774-778
67. Hollenberg S.M., Tangora J.J., Piotrowski M.J., et al. Impaired microvascular vasoconstrictive responses to vasopressin in septic rats. Crit Care Med 25 5 (1997) 869-873
68. Price S.A., Spain D.A., Wilson M.A., et al. Subacute sepsis impairs vascular smooth muscle contractile machinery and alters vasoconstrictor and dilator mechanisms. J Surg Res 83 1 (1999) 75-80
69. Bakker J., Grover R., McLuckie A., et al. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Crit Care Med 32 1 (2004) 1-12
70. Hollenberg S.M., Cunnion R.E., and Zimmerberg J. Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats. Am J Physiol 264 2 Pt 2 (1993) H660-H663
71. Hollenberg S.M., Easington C.R., Osman J., et al. Effects of nitric oxide synthase inhibition on microvascular reactivity in septic mice. Shock 12 4 (1999) 262-267
72. Hollenberg S.M., Piotrowski M.J., and Parrillo J.E. Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to endothelin-1 in septic rats. Am J Physiol 272 3 Pt 2 (1997) R969-R974
73. Watson D., Grover R., Anzueto A., et al. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Crit Care Med 32 1 (2004) 13-20
74. Anning P.B., Sair M., Winlove C.P., et al. Abnormal tissue oxygenation and cardiovascular changes in endotoxemia. Am J Respir Crit Care Med 159 6 (1999) 1710-1715
75. Avontuur J.A., Bruining H.A., and Ince C. Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats. Circ Res 76 3 (1995) 418-425
76. Corso C.O., Gundersen Y., Dorger M., et al. Effects of the nitric oxide synthase inhibitors N(G)-nitro-l-arginine methyl ester and aminoethyl-isothiourea on the liver microcirculation in rat endotoxemia. J Hepatol 28 1 (1998) 61-69
77. Kubes P., and Granger D.N. Nitric oxide modulates microvascular permeability. Am J Physiol 262 2 Pt 2 (1992) H611-H615
78. Nishida J., McCuskey R.S., McDonnell D., et al. Protective role of NO in hepatic microcirculatory dysfunction during endotoxemia. Am J Physiol 267 6 Pt 1 (1994) G1135-G1141
79. Spain D.A., Wilson M.A., Bar-Natan M.F., et al. Nitric oxide synthase inhibition aggravates intestinal microvascular vasoconstriction and hypoperfusion of bacteremia. J Trauma 36 5 (1994) 720-725
80. Spain D.A., Wilson M.A., Bloom I.T., et al. Renal microvascular responses to sepsis are dependent on nitric oxide. J Surg Res 56 6 (1994) 524-529
81. Spain D.A., Wilson M.A., and Garrison R.N. Nitric oxide synthase inhibition exacerbates sepsis-induced renal hypoperfusion. Surgery 116 2 (1994) 322-330 [discussion: 330-1]
82. Tribl B., Bateman R.M., Milkovich S., et al. Effect of nitric oxide on capillary hemodynamics and cell injury in the pancreas during Pseudomonas pneumonia-induced sepsis. Am J Physiol Heart Circ Physiol 286 1 (2004) H340-H345
83. Binion D.G., Fu S., Ramanujam K.S., et al. iNOS expression in human intestinal microvascular endothelial cells inhibits leukocyte adhesion. Am J Physiol 275 3 Pt 1 (1998) G592-G603
84. Sundrani R., Easington C.R., Mattoo A., et al. Nitric oxide synthase inhibition increases venular leukocyte rolling and adhesion in septic rats. Crit Care Med 28 8 (2000) 2898-2903
85. Hickey M.J., Granger D.N., and Kubes P. Inducible nitric oxide synthase (iNOS) and regulation of leucocyte/endothelial cell interactions: studies in iNOS-deficient mice. Acta Physiol Scand 173 1 (2001) 119-126
86. Hickey M.J., Sharkey K.A., Sihota E.G., et al. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J 11 12 (1997) 955-964
87. Lush C.W., Cepinskas G., Sibbald W.J., et al. Endothelial E- and P-selectin expression in iNOS-deficient mice exposed to polymicrobial sepsis. Am J Physiol Gastrointest Liver Physiol 280 2 (2001) G291-G297
88. Dellinger R.P., and Parrillo J.E. Mediator modulation therapy of severe sepsis and septic shock: does it work?. Crit Care Med 32 1 (2004) 282-286
89. Lopez A., Lorente J.A., Steingrub J., et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32 1 (2004) 21-30
90. De Caterina R., Libby P., Peng H.B., et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96 1 (1995) 60-68
91. Boughton-Smith N.K., Hutcheson I.R., Deakin A.M., et al. Protective effect of S-nitroso-N-acetyl-penicillamine in endotoxin-induced acute intestinal damage in the rat. Eur J Pharmacol 191 3 (1990) 485-488
92. Gundersen Y., Corso C.O., Leiderer R., et al. The nitric oxide donor sodium nitroprusside protects against hepatic microcirculatory dysfunction in early endotoxaemia. Intensive Care Med 24 12 (1998) 1257-1263
93. Siegemund M., van Bommel J., Vollebrecht K., et al. Influence of nitric oxide donor SIN-1 on the gut oxygenation in a normodynamic, porcine model of low-dose endotoxemia. [abstract]. Intensive Care Med 26 (2000) S362
94. Zhang H., Rogiers P., Smail N., et al. Effects of nitric oxide on blood flow distribution and O2 extraction capabilities during endotoxic shock. J Appl Physiol 83 4 (1997) 1164-1173
95. Spronk P.E., Ince C., Gardien M.J., et al. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 360 9343 (2002) 1395-1396
96. Spronk P., Ince C., Gardien M., et al. Nitroglycerin for septic shock. Lancet 361 9360 (2003) 880
97. Randomized Trial of Inhaled Nitric Oxide to Augment Tissue Perfusion in Sepsis (NCT00608322). Available at:. http://www.ClinicalTrials.gov National Library of Medicine, Bethesda. Accessed May, 2009
98. The Effect of Nitroglycerine on Microcirculatory Abnormalities During Sepsis (NCT00493415). Available at:. http://www.ClinicalTrials.gov National Library of Medicine, Bethesda. Accessed May, 2009
99. Abraham E., and Singer M. Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 35 10 (2007) 2408-2416
100. Cinel I., and Dellinger R.P. Advances in pathogenesis and management of sepsis. Curr Opin Infect Dis 20 4 (2007) 345-352
101. Fink M.P. Bench-to-bedside review: cytopathic hypoxia. Crit Care 6 6 (2002) 491-499
102. Hotchkiss R.S., and Karl I.E. Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. JAMA 267 11 (1992) 1503-1510
103. Watts J.A., and Kline J.A. Bench to bedside: the role of mitochondrial medicine in the pathogenesis and treatment of cellular injury. Acad Emerg Med 10 9 (2003) 985-997
104. Singer M., De Santis V., Vitale D., et al. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 364 9433 (2004) 545-548